Minnesota urological device company raising $1 million

GT UrologicalMINNEAPOLIS, Minnesota — GT Urological wants to raise $1 million to continue with research and development of a implantable male incontinence device.

GT Urological already has one product: the ActiCuf pouch that externally manages incontinence in men. But the company has received more than $2 million in federal research and business development grants to create implantable devices for men and women that would re-establish urinary control and provide “on demand” control of bladder functions.

Chief Financial Officer Jeff Shapiro said the new money would continue research on the men’s version of the product. A version for women is “down the road,” Shapiro said, though he declined to give a commercilization timetable for either device.

This is the first time the company has raised private equity. In July it selected as its chief medical advisor Dr. Steven Siegel, director of Continence Care at Metro Urology in St. Paul.

Reblog this post [with Zemanta]
Chris Seper

Chris Seper MedCity News

Chris Seper is the CEO at MedCity Media, which publishes MedCityNews.com. He is also a senior writer at MedCity News. Reach him at chris@medcitynews.com.

more

Comments RSS Post a comment

[...] for a clinical trial early next year; GT Urological, also in Minneapolis, wants to raise $1 million to continue with research and development of a implantable male incontinence device; and Cardinal [...]

Comment by Weekend Rounds: Some docs mad as hell; Midwest researchers win big : MedCity News — September 26, 2009 @ 1:49 pm

Post a Comment

Submit Comment

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Jobs Board


MedCity Whitepapers

Real Time Web Analytics